130
Views
5
CrossRef citations to date
0
Altmetric
Review

Optimal management of Barrett’s esophagus: pharmacologic, endoscopic, and surgical interventions

&
Pages 447-458 | Published online: 22 Nov 2011

References

  • PohlHWelchHGThe role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidenceJ Natl Cancer Inst200597214214615657344
  • EnzingerPCMayerRJEsophageal cancerN Engl J Med2003349232241225214657432
  • FitzgeraldRCLascarRTriadafilopoulosGReview article: Barrett’s oesophagus, dysplasia and pharmacologic acid suppressionAliment Pharmacol Ther200115326927611207503
  • ZehetnerJDeMeesterSRAyaziSLong-term follow-up after anti-reflux surgery in patients with Barrett’s esophagusJ Gastrointest Surg201014101483149120824377
  • CooperBTBarbezatGOTreatment of Barrett’s esophagus with H2 blockersJ Clin Gastroenterol1987921391412883213
  • NeumannCSIqbalTHCooperBTLong term continuous omeprazole treatment of patients with Barrett’s oesophagusAliment Pharmacol Ther1995944514548527623
  • PetersFTGaneshSKuipersEJEndoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind studyGut199945448949410486353
  • GoreSHealeyCJSuttonRRegression of columnar lined (Barrett’s) oesophagus with continuous omeprazole therapyAliment Pharmacol Ther1993766236288161668
  • SamplinerREEffect of up to 3 years of high-dose lansoprazole on Barrett’s esophagusAm J Gastroenterol19948910184418487942680
  • CooperBTNeumannCSCoxMAIqbalTHContinuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett’s oesophagusAliment Pharmacol Ther19981298938979768533
  • WilkinsonSPBiddlestoneLGoreSShepherdNARegression of columnar-lined (Barrett’s) oesophagus with omeprazole 40 mg daily: Results of 5 years of continuous therapyAliment Pharmacol Ther19991391205120910468702
  • MalesciASavarinoVZentilinPPartial regression of Barrett’s esophagus by long-term therapy with high-dose omeprazoleGastrointest Endosc19964467007058979061
  • CooperBTChapmanWNeumannCSGeartyJCContinuous treatment of Barrett’s oesophagus patients with proton pump inhibitors up to 13 years: Observations on regression and cancer incidenceAliment Pharmacol Ther200623672773316556174
  • SharmaPSamplinerRECamargoENormalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagusAm J Gastroenterol19979245825859128303
  • SamplinerREReduction of acid exposure and regression of Barrett’s esophagusDig Dis200018420320711356991
  • WestonAPBadrASHassaneinRSProspective multivariate analysis of factors predictive of complete regression of Barrett’s esophagusAm J Gastroenterol199994123420342610606297
  • GatenbyPARamusJRCaygillCPCharlettAWinsletMCWatsonATreatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagusDis Esophagus200922213314219018855
  • El-SeragHBAguirreTVDavisSKuebelerMBhattacharyyaASamplinerREProton pump inhibitors are associated with reduced incidence of dysplasia in Barrett’s esophagusAm J Gastroenterol200499101877188315447744
  • NguyenDMEl-SeragHBHendersonLSteinDBhattacharyyaASamplinerREMedication usage and the risk of neoplasia in patients with Barrett’s esophagusClin Gastroenterol Hepatol20097121299130419523538
  • HillmanLCChiragakisLShadboltBKayeGLClarkeACProton-pump inhibitor therapy and the development of dysplasia in patients with Barrett’s oesophagusMed J Aust2004180838739115089728
  • HeathCWJrThunMJGreenbergERLevinBMarnettLJNonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshopCancer19947410288528887954252
  • CorleyDAKerlikowskeKVermaRBufflerPProtective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysisGastroenterology20031241475612512029
  • FosslienEMolecular pathology of cyclooxygenase-2 in neoplasiaAnn Clin Lab Sci200030132110678579
  • SouzaRFShewmakeKBeerDGCryerBSpechlerSJSelective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cellsCancer Res200060205767577211059772
  • MorrisCDArmstrongGRBigleyGGreenHAttwoodSECyclooxygenase-2 expression in the Barrett’s metaplasia-dysplasia-adenocarcinoma sequenceAm J Gastroenterol200196499099611316217
  • ButtarNSWangKKAndersonMAThe effect of selective cyclooxygenase-2 inhibition in Barrett’s esophagus epithelium: An in vitro studyJ Natl Cancer Inst200294642242911904314
  • VaughanTLDongLMBlountPLNon-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: A prospective studyLancet Oncol200561294595216321762
  • AndersonLAJohnstonBTWatsonRGNonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequenceCancer Res20066694975498216651456
  • NguyenDMRichardsonPEl-SeragHBMedications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett’s esophagusGastroenterology201013872260226620188100
  • SpechlerSJSharmaPSouzaRFInadomiJMShaheenNJAmerican Gastroenterological Association medical position statement on the management of Barrett’s esophagusGastroenterology201114031084109121376940
  • HenryDLimLLGarcia RodriguezLAVariability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysisBMJ1996312704615631566
  • HeathEICantoMIPiantadosiSSecondary chemoprevention of Barrett’s esophagus with celecoxib: Results of a randomized trialJ Natl Cancer Inst200799754555717405999
  • WangKKSamplinerREUpdated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagusAm J Gastroenterol2008103378879718341497
  • ChennatJSKondaVJWaxmanIEndotherapy for Barrett’s esophagus: Which, how, when and who?Gastrointest Endosc Clin N Am201121111913321112502
  • SharmaPDentJArmstrongDThe development and validation of an endoscopic grading system for Barrett’s esophagus: The Prague C and M criteriaGastroenterology200613151392139917101315
  • MannathJSubramanianVHawkeyCJRagunathKNarrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: A meta-analysisEndoscopy201042535135920200809
  • CurversWLBohmerCJMallant-HentRCMucosal morphology in Barrett’s esophagus: Interobserver agreement and role of narrow band imagingEndoscopy2008401079980518828075
  • KaraMAPetersFPTenKateVanFJDeventerSJFockensPBergmanJJEndoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett’s esophagusGastrointest Endosc200561667968515855971
  • WaxmanIKondaVJEndoscopic techniques for recognizing neoplasia in Barrett’s esophagus: Which should the clinician use?Curr Opin Gastroenterol201026435236020571387
  • DunbarKBOkoloP3rdMontgomeryECantoMIConfocal laser endomicroscopy in Barrett’s esophagus and endoscopically inapparent Barrett’s neoplasia: A prospective, randomized, double-blind, controlled, crossover trialGastrointest Endosc200970464565419559419
  • MontgomeryEBronnerMPGoldblumJRReproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmationHum Pathol200132436837811331953
  • OrmsbyAHPetrasREHenricksWHObserver variation in the diagnosis of superficial oesophageal adenocarcinomaGut200251567167612377805
  • KerkhofMvan DekkenHSteyerbergEWGrading of dysplasia in Barrett’s oesophagus: Substantial interobserver variation between general and gastrointestinal pathologistsHistopathology200750792092717543082
  • ChennatJKondaVJRossASComplete Barrett’s eradication endoscopic mucosal resection: An effective treatment modality for high-grade dysplasia and intramucosal carcinoma – an American single-center experienceAm J Gastroenterol2009104112684269219690526
  • WaniSMathurSCCurversWLGreater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasiaClin Gastroenterol Hepatol20108978378820472096
  • FergusonMKNaunheimKSResection for Barrett’s mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapyJ Thorac Cardiovasc Surg199711458248299375613
  • KondaVJRossASFergusonMKIs the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated?Clin Gastroenterol Hepatol20086215916418096439
  • ParafFFlejouJFPignonJPFeketeFPotetFSurgical pathology of adenocarcinoma arising in Barrett’s esophagus. Analysis of 67 casesAm J Surg Pathol19951921831917832278
  • FeithMSteinHJSiewertJRPattern of lymphatic spread of Barrett’s cancerWorld J Surg20032791052105712917758
  • SteinHJFeithMBruecherBLNaehrigJSarbiaMSiewertJREarly esophageal cancer: Pattern of lymphatic spread and prognostic factors for long-term survival after surgical resectionAnn Surg2005242456657316192817
  • RiceTWZuccaroGJrAdelsteinDJRybickiLABlackstoneEHGoldblumJREsophageal carcinoma: Depth of tumor invasion is predictive of regional lymph node statusAnn Thorac Surg19986537877929527214
  • LopesCVHelaMPesentiCCircumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinomaSurg Endosc200721582082417294308
  • van SandickJWvan LanschotJJten KateFJPathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: Implications for therapeutic decision makingCancer200088112429243710861416
  • WaxmanIKondaVJMucosal ablation of Barrett esophagusNat Rev Gastroenterol Hepatol20096739340119488071
  • EllCMayAGossnerLEndoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagusGastroenterology2000118467067710734018
  • LarghiALightdaleCJMemeoLBhagatGOkparaNRotterdamHEUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagusGastrointest Endosc2005621162315990814
  • MayAGossnerLPechOLocal endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: Acute-phase and intermediate results of a new treatment approachEur J Gastroenterol Hepatol200214101085109112362099
  • MayAGossnerLPechOIntraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): Curative treatment using local endoscopic treatment techniquesEndoscopy200234860461012173079
  • Mino-KenudsonMBruggeWRPuricelliWPManagement of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: Clinicopathologic analysis of 27 casesAm J Surg Pathol200529568068615832094
  • NijhawanPKWangKKEndoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagusGastrointest Endosc200052332833210968845
  • PechOMayAGossnerLEllCBarrett’s esophagus: Endoscopic resectionGastrointest Endosc Clin N Am200313350551214629106
  • ButtarNSWangKKSeboTJExtent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinomaGastroenterology200112071630163911375945
  • SeewaldSAngTLGotodaTSoehendraNTotal endoscopic resection of Barrett esophagusEndoscopy200840121016102019065485
  • PechOBehrensAMayALong-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagusGut20085791200120618460553
  • PetersFPKaraMARosmolenWDStepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: A prospective studyAm J Gastroenterol200610171449145716863545
  • SeewaldSAkaraviputhTSeitzUCircumferential EMR and complete removal of Barrett’s epithelium: A new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinomaGastrointest Endosc200357785485912776032
  • PouwRESeewaldSGondrieJJStepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patientsGut20105991169117720525701
  • WangKKPrasadGTianJEndoscopic mucosal resection and endoscopic submucosal dissection in esophageal and gastric cancersCurr Opin Gastroenterol201026545345820703112
  • YoshinagaSGotodaTKusanoCOdaINakamuraKTakayanagiRClinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junctionGastrointest Endosc200867220220918226681
  • van VilsterenFGPouwRESeewaldSStepwise radical endoscopic resection versus radiof-requency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trialGut201160676577321209124
  • SharmaVKWangKKOverholtBFBalloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patientsGastrointest Endosc200765218519517258973
  • FleischerDEOverholtBFSharmaVKEndoscopic ablation of Barrett’s esophagus: A multicenter study with 2.5-year follow-upGastrointest Endosc200868586787618561930
  • FleischerDEOverholtBFSharmaVKEndoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trialEndoscopy2010421078178920857372
  • ShaheenNJSharmaPOverholtBFRadiofrequency ablation in Barrett’s esophagus with dysplasiaN Engl J Med2009360222277228819474425
  • GanzRAOverholtBFSharmaVKCircumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: A US Multicenter RegistryGastrointest Endosc2008681354018355819
  • PouwREWirthsKEisendrathPEfficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasiaClin Gastroenterol Hepatol201081232919602454
  • GrossSAWolfsenHCThe role of photodynamic therapy in the esophagusGastrointest Endosc Clin N Am20102013553vi19951793
  • OverholtBFPanjehpourMHalbergDLPhotodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: Long-term resultsGastrointest Endosc200358218318812872083
  • PechOGossnerLMayALong-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasiaGastrointest Endosc2005621243015990815
  • PrasadGAWangKKButtarNSWongkeesongLMLutzkeLSBorkenhagenLSPredictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagusGastrointest Endosc2007651606617185080
  • Van LaethemJLPenyMOSalmonICremerMDeviereJIntramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagusGut200046457457710716690
  • KuflikEGCryosurgery updatedJ Am Acad Dermatol19943169259447962774
  • DumotJAVargoJJ2ndFalkGWFreyLLopezRRiceTWAn openlabel, prospective trial of cryospray ablation for Barrett’s esophagus high-grade dysplasia and early esophageal cancer in high-risk patientsGastrointest Endosc200970463564419559428
  • GreenwaldBDDumotJAHorwhatJDLightdaleCJAbramsJASafety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagusDis Esophagus2010231131919515183
  • ShaheenNJGreenwaldBDPeeryAFSafety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasiaGastrointest Endosc201071468068520363409
  • ShaheenNJPeeryAFOverholtBFBiopsy depth after radiofrequency ablation of dysplastic Barrett’s esophagusGastrointest Endosc2010723490e.1496e.120598302
  • BozioGBaulieuxJMabrutJYThe role of surgery in the management of Barrett’s esophagus (from dysplasia to cancer)J Visc Surg20111481192621310681
  • KondaVJFergusonMKEsophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?World J Gastroenterol201016303786379220698041
  • BaileySHBullDAHarpoleDHOutcomes after esophagectomy: A ten-year prospective cohortAnn Thorac Surg200375121722212537219
  • BirkmeyerJDStukelTASiewersAEGoodneyPPWennbergDELucasFLSurgeon volume and operative mortality in the United StatesN Engl J Med2003349222117212714645640
  • LawSEsophagectomy without mortality: What can surgeons do?J Gastrointest Surg201014Suppl 1S101S10719774427
  • FernandoHCMurthySCHofstetterWThe Society of Thoracic Surgeons practice guideline series: Guidelines for the management of Barrett’s esophagus with high-grade dysplasiaAnn Thorac Surg20098761993200219463651
  • RiceTWPro: Esophagectomy is the treatment of choice for high-grade dysplasia in Barrett’s esophagusAm J Gastroenterol2006101102177217917032178
  • ReedMFTolisGJrEdilBHSurgical treatment of esophageal high-grade dysplasiaAnn Thorac Surg20057941110111515797034
  • TsengEEWuTTYeoCJHeitmillerRFBarrett’s esophagus with high grade dysplasia: Surgical results and long-term outcome – an updateJ Gastrointest Surg20037216417012600440
  • HeadrickJRNicholsFC3rdMillerDLHigh-grade esophageal dysplasia: Long-term survival and quality of life after esophagectomyAnn Thorac Surg20027361697170212078755
  • ChangLCOelschlagerBKQuirogaELong-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett’s esophagusJ Gastrointest Surg200610334134616504878
  • WolfsenHCHemmingerLLDeVaultKRRecurrent Barrett’s esophagus and adenocarcinoma after esophagectomyBMC Gastroenterol200441815327696
  • OrringerMBMarshallBIannettoniMDTranshiatal esophagectomy: Clinical experience and refinementsAnn Surg1999230339240010493486
  • HulscherJBvan SandickJWde BoerAGExtended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagusN Engl J Med2002347211662166912444180
  • WolffCSCastilloSFLarsonDRIvorLewisapproach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomyDis Esophagus2008214328333
  • BiereSSCuestaMAvan der PeetDLMinimally invasive versus open esophagectomy for cancer: A systematic review and meta-analysisMinerva Chir200964212113319365313
  • BiereSSMaasKWBonavinaLTraditional invasive vs minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial)BMC Surg201111221226918
  • DeckerGCoosemansWDe LeynPMinimally invasive esophagectomy for cancerEur J Cardiothorac Surg2009351132018952454
  • PeyreCGDeMeesterSRRizzettoCVagal-sparing esophagectomy: The ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasiaAnn Surg2007246466567117893503
  • LagergrenJViklundPIs esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux?World J Surg200731346546917171490
  • O’RiordanJMByrnePJRaviNKeelingPWReynoldsJVLong-term clinical and pathologic response of Barrett’s esophagus after antireflux surgeryAm J Surg20041881273315219481
  • ParrillaPMartinez de HaroLFLong-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagusAnn Surg2003237329129812616111